Obesity-associated metabolic disturbances can impair the function of the pancreas, particularly in insulin-secreting β-cells and it has been unequivocally proven in prior studies that β-cell mass reduces before the development of T2D (Weir et al., 2020). The gene discussed is INS; the disease is obesity disorder.